Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
Mitogen-activated protein (MAP) kinases are proline-directed serine/threonine kinases that are activated by dual phosphorylation on threonine and tyrosine residues in response to a wide array of extracellular stimuli. Three distinct groups of MAP kinases have been identified in mammalian cells [extracellular-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38]. These MAP kinases are mediators of signal transduction from the cell surface to the nucleus. One nuclear target of these MAP kinase signaling pathways is the transcription factor AP-1. MAP kinases regulate AP-1 transcriptional activity by multiple mechanisms. Here we review recent progress towards understanding AP-1 regulation by the ERK, JNK, and p38 MAP kinase signal transduction pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“c-Jun forms homodimers or can heterodimerize with other Jun family members or with other bZIP proteins including members of the Fos and ATF/cAMP response element-binding protein (CREB) families (18,19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [18]
In the citing paper
“The c-Jun promoter contains important TPA response elements that preferentially bind heterodimers of c-Jun and ATF-2, both of which are activated upon phosphorylation by JNK (17)(18)(19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [18]
In the citing paper
“Usually, c-Jun forms heterodimers with c-Fos in AP-1 transcription factor complexes (17)(18)(19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [18]
In the citing paper
“Usually, c-Jun forms heterodimers with c-Fos in AP-1 transcription factor complexes [69, 70].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [70]
Citations
Cites
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,287
Self-citationMarshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Keys, J. R., Land vatter, S. W., et al. (1994) · Nature · doi:10.1038/372739a0 · Cited by 3,288
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Self-citationIntegrins and Signal Transduction Pathways: the Road Taken
Clark, E. A., & Brugge, J. S. (1995) · Science · doi:10.1126/science.7716514 · Cited by 2,937
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J.-D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,646
The stress-activated protein kinase subfamily of c-Jun kinases
Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., & Woodgett, J. R. (1994) · Nature · doi:10.1038/369156a0 · Cited by 2,596
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7420 · Cited by 2,241
Self-citation
Cited by
Items 601–700 of 1,001
Signal Transduction by VIP and PACAP Receptors
Langer, I., Jeandriens, J., Couvineau, A., Sanmukh, S. G., & Latek, D. (2022) · Biomedicines · doi:10.3390/biomedicines10020406 · Cited by 54
“As was mentioned above, VIP and PACAP receptors are used in molecular imaging at different cancer stages, including tumor formation and progression [30,31,33,34].”
BackgroundZama, T., Aoki, R., Kamimoto, T., Inoue, K., Ikeda, Y., & Hagiwara, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200838200 · Cited by 54
Liu, T., Chen, C., Yiin, S., Chen, C., Cheng, J., Shih, M., Wang, Y., & Chern, C. (2005) · Food and Chemical Toxicology · doi:10.1016/j.fct.2005.07.003 · Cited by 53
DeMorrow, S., Francis, H., Gaudio, E., Ueno, Y., Venter, J. K., Onori, P., Franchitto, A., Vaculin, B. T., Vaculin, S., & Alpini, G. D. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00304.2007 · Cited by 57
“In addition, when interpreting the present data, it must be acknowledged that the AP-1 pathway does not function in isolation but has been shown previously to interact with such signaling pathways as STAT (47), NF- B (16), and MAPK (68), all of which have been shown previously to regulate cholangiocyte growth (1, 50,…”
BackgroundXu, X., Xu, H., Qimuge, A., Liu, S., Wang, H., Hu, M., & Song, L. (2018) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2018.11.124 · Cited by 56
Ghosh, J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01201-4 · Cited by 62
p38 MAP kinase regulates IL-1β responses in cultured airway smooth muscle cells
Laporte, J. D., Moore, P. E., Lahiri, T., Schwartzman, I. N., Panettieri, R. A., & Shore, S. A. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.5.l932 · Cited by 53
Ling, H. Y., Jia, X., Zhang, Y., Gapter, L. A., Lim, Y., Agarwal, R., & Ng, K. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20597 · Cited by 54
“However, further studies are needed to clarify the direct effects of PA on c-Jun, c-Fos, ATF-2, and AP-1 activity.”
BackgroundInfluentialRegulation of T lymphocyte activation by microRNA-21
Wang, L., He, L., Zhang, R., Liu, X., Ren, Y., Liu, Z., Zhang, X., Cheng, W., & Hua, Z.-C. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.02.004 · Cited by 56
Rodrigues, C. F. D., Urbano, A. M., Matoso, E., Carreira, I. M., Almeida, A., Santos, P., Botelho, M. F., Carvalho, L., Alves, M., Monteiro, C. E., et al. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.07.004 · Cited by 63
Huang, T., Lai, H., Chen, Y.-B., Chen, L.-G., Wu, Y., Ko, Y., Lu, C., Chang, C., Wu, C.-Y., Martel, J., et al. (2013) · Innate Immunity · doi:10.1177/1753425913507096 · Cited by 55
JAK-STAT-dependent regulation of scavenger receptors in LPS-activated murine macrophages
Hashimoto, R., Kakigi, R., Miyamoto, Y., Nakamura, K., Itoh, S., Daida, H., Okada, T., & Katoh, Y. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172940 · Cited by 56
Kalamon, N., Błaszczyk, K., Szlaga, A., Billert, M., Skrzypski, M., Pawlicki, P., Górowska-Wójtowicz, E., Balak, M. K. –., Błasiak, A., & Rak, A. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.05.101 · Cited by 53
VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cells
Moody, T. W., Leyton, J., Chan, D. C. F., Brenneman, D. C., Fridkin, M., Gelber, E., Levy, A., & Gozes, I. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1017994722130 · Cited by 52
“The elevated cAMP may activate protein kinase (PK) A which phosphorylates cellular proteins such as CREB [32].”
Kumagai, T., Nakamura, Y., Osawa, T., & Uchida, K. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2601 · Cited by 52
The concept of glomerular self-defense
Kitamura, M., & Fine, L. G. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00425.x · Cited by 57
“The family of mitogen-activated protein kinases (MAP kinases), including extracellular signal-regulated kinase (ERK), JNK, and p38 MAP kinase, plays a crucial part in cellular activation in response to a broad array of extracellular stimul”
BackgroundJohansen, C., Kragballe, K., Iversen, L., Henningsen, J., Westergaard, M., & Kristiansen, K. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12095.x · Cited by 52
Lee, J.-W., Kim, Y. I., Im, C., Kim, S. W., Kim, S. J., Min, S., Joo, Y. H., Yim, S., & Chung, N. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b00923 · Cited by 53
Kogut, M. H., Genovese, K. J., He, H., & Kaiser, P. (2008) · Innate Immunity · doi:10.1177/1753425908094416 · Cited by 52
Neo, S. Y., Zhang, Y., Yaw, L. P., Li, P., & Lin, S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2751 · Cited by 57
Vascular smooth muscle cell proliferation requires both p38 and BMK1 MAP kinases
Zhao, M. F., Liu, Y., Bao, M., Kato, Y., Han, J., & Eaton, J. W. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00028-0 · Cited by 52
CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell
Song, Q., Yi, F., Zhang, Y., Li, D. K. J., Wei, Y., Yu, H., & Zhang, Y. (2019) · BMC Cancer · doi:10.1186/s12885-019-5671-8 · Cited by 69
“Key kinases and adaptors in signaling transduction pathways are known to regulate gene transcription [69].”
BackgroundMorin (2′,3,4′,5,7-Pentahydroxyflavone) Protected Cells against γ-Radiation-Induced Oxidative Stress
Zhang, R., Kang, K. A., Kang, S. S., Park, J.-W., & Hyun, J. W. (2010) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2010.00629.x · Cited by 58
Checker, R., Patwardhan, R. S., Sharma, D., Menon, J., Thoh, M., Sandur, S. K., Sainis, K. B., & Poduval, T. B. (2013) · Inflammation · doi:10.1007/s10753-013-9768-y · Cited by 50
Vasoactive intestinal peptide receptor-based imaging and treatment of tumors
TANG, B., YONG, X., Xie, R., Li, Q., & Yang, S. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2276 · Cited by 50
“Research has shown that the addition of VIP to lung cancer cells elevated the cAMP levels and led to the activation of a series of transcription factors that promoted the expression of nuclear oncogenes and growth factors (46,47).”
BackgroundLi, L., Han, M., Li, S., Wang, L. Q., & Xu, Y. (2013) · DNA and Cell Biology · doi:10.1089/dna.2013.2070 · Cited by 50
“The most important kinases involved in mechano transduction are the MAPKs, because most mechanical signals are transmitted to the nucleus through the activation of these kinases (Whitmarsh and Davis, 1996; Liedert et al., 2006).”
BackgroundFerrer, I., Blanco, R., Carmona, M., & Puig, B. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2001.00348.x · Cited by 50
Intervention by retinoic acid in oxidative stress-induced apoptosis
Kitamura, M. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_9.84 · Cited by 50
Hashimoto, S., Gon, Y., Matsumoto, K., Takeshita, I., Maruoka, S., & Horie, T. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.3.9911099 · Cited by 50
“JNK has been implicated in the activation of multiple transcription factors, including AP-1 (34, 35 ).”
BackgroundMestas, J., & Hughes, C. C. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4378 · Cited by 50
Differential Involvement of Phosphoinositide 3-Kinase/Akt in Human RPE MCP-1 and IL-8 Expression
Bian, Z.-M., Elner, S. G., Yoshida, A., & Elner, V. M. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0608 · Cited by 50
Palytoxin: exploiting a novel skin tumor promoter to explore signal transduction and carcinogenesis
Wattenberg, E. V. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00254.2006 · Cited by 50
“Although JNK, p38, and ERK are often activated by different signals, the three major MAP kinases can modulate some common targets, such as the transcription factor Elk-1, which regulates the expression of c-Fos, and the AP-1 family of transcription factors, which are dimers made up of various combinations of Jun and F…”
Lin, Z., Chen, C., Yang, D., Ding, J., Wang, G., & Ren, H. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04002-1 · Cited by 49
“MAPKs including ERK, JNK, and p38 are required for AP-1 activation to induce the expression of inflammatory factors [42, 43].”
BackgroundPhytoconstituents as apoptosis inducing agents: strategy to combat cancer
Kumar, M., Kaur, V., Kumar, S., & Kaur, S. (2015) · Cytotechnology · doi:10.1007/s10616-015-9897-2 · Cited by 60
Eğrilmez, M. Y., Okajima, K., Uchiba, M., & Okabe, H. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041988 · Cited by 51
“Activation of JNK and p38 MAPK by dual phosphorylation was shown to enhance the transcriptional activity of AP-1 (Whitmarsh and Davis, 1996); while gabexate mesilate has been demonstrated to inhibit LPS-induced phosphorylation of JNK and p38 MAPK.”
BackgroundInfluentialWang, F., Zhou, H., Du, Z., Chen, X., Zhu, F., Wang, Z., Zhang, Y., Lin, L., Qian, M., Zhang, X., et al. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.09.033 · Cited by 51
Sang, X., Li, B., Ze, Y., Hong, J., Ze, X., Gui, S., Sun, Q., Liu, H., Zhao, X., Sheng, L., et al. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf3035989 · Cited by 51
Kook, S., Son, Y., Chung, S.-W., Lee, S., Kim, J., Jeon, Y., & Lee, J. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0056-x · Cited by 49
“MAPK families such as ERK, JNK, and p38 tightly regulate the expression and activity of the Jun and Fos family [36].”
BackgroundAskari, N., Diskin, R., Avitzour, M., Capone, R. F., Livnah, O., & Engelberg, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608012200 · Cited by 51
Deng, R., Yang, D., Radke, A. L., Yang, J., & Yan, B. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.113837 · Cited by 52
“Activation of the Jun family is achieved mainly by the c-Jun N-terminal kinase (JNK), whereas extracellular signal-regulated kinase (ERK) mediates activation of Fos family (Whitmarsh and Davis, 1996; Dhanasekaran and Premkumar Reddy, 1998).”
BackgroundTack, I., Elliot, S. J., Potier, M., Rivera, A., Striker, G. E., & Striker, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.1.182 · Cited by 49
“ERK1 and -2 are activated by phosphorylation of their tyrosine residues (16).”
BackgroundKim, D. K., Cho, E. S., Seong, J. K., & Um, H. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.23.4329 · Cited by 49
Dixon, M., Agius, L., Yeaman, S. J., & Day, C. P. (1999) · Hepatology · doi:10.1002/hep.510290516 · Cited by 49
Regulation of Toll-like receptor 4 signalling by A20 zinc finger protein
O’Reilly, S. M., & Moynagh, P. N. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00389-9 · Cited by 49
Reichman, T. W., Albanell, J., Wang, X., Moore, M. A. S., & Studzinski, G. P. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19971001)67:1<13::aid-jcb2>3.0.co;2-z · Cited by 41
Self-citationInteraction of Transcription Factors with Serum Response Factor
Ling, Y., West, A. G., Roberts, E. C., Lakey, J. H., & Sharrocks, A. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10506 · Cited by 49
Martin, L. J., Boucher, N., El‐Asmar, B., & Tremblay, J. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.006387 · Cited by 56
Therapeutic effect of c‐Jun N‐terminal kinase inhibition on pancreatic cancer
Takahashi, R., Hirata, Y., Sakitani, K., Nakata, W., Kinoshita, H., Hayakawa, Y., Nakagawa, H., Sakamoto, K., Hikiba, Y., Ijichi, H., et al. (2013) · Cancer Science · doi:10.1111/cas.12080 · Cited by 51
Shimohata, T., Nakano, M., Lian, X., Shigeyama, T., Iba, H., Hamamoto, A., Yoshida, M., Harada, N., Yamamoto, H., Yamato, M., et al. (2010) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq070 · Cited by 48
Maugeri, G., D’Amico, A. G., Reitano, R., Magro, G. G., Cavallaro, S., Salomone, S., & D’Agata, V. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00139 · Cited by 53
“VIPRs, stimulate a series of transcription factors, which promote proliferation, expression of nuclear oncogenes and growth factors in different cell lines (Whitmarsh and Davis, 1996; Casibang et al., 2001).”
BackgroundAbounader, R., Ranganathan, S., Kim, B. Y. S., Nichols, C. D., & Laterra, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00158.x · Cited by 49
Li, J. Y., Wang, H., May, S., Song, X., Fueyo, J., Fuller, G. N., & Wang, H. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9529-1 · Cited by 48
“JNK is activated by various stimuli, such as cellular stressors and cytokines [ 14 ].”
BackgroundCha, J., Moon, S., Kim, H., Cha, I., & Lee, K. (2009) · Journal of Food Science · doi:10.1111/j.1750-3841.2009.01355.x · Cited by 47
Zama, T., Aoki, R., Kamimoto, T., Inoue, K., Ikeda, Y., & Hagiwara, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200837200 · Cited by 48
Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors
Weiner, S. J., & Neragi-Miandoab, S. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0444-9 · Cited by 56
Moriyama, I., Ishihara, S., Rumi, M. A. K., Aziz, M., Mishima, Y., Oshima, N., Kadota, C., Kadowaki, Y., Amano, Y., & Kinoshita, Y. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.38 · Cited by 52
Activation of the Calcium-permeable Cation Channel CD20 by α Subunits of the Gi Protein
Kanzaki, M., Lindorfer, M. A., Garrison, J. C., & Kojima, I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14733 · Cited by 48
The role of acid and bile reflux in oesophagitis and Barrett's metaplasia
Souza, R. F. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380348 · Cited by 48
Hu, X., Flaws, J. A., Sipes, I. G., & Hoyer, P. B. (2002) · Biology of Reproduction · doi:10.1095/biolreprod.102.004259 · Cited by 50
Ahn, J. D., Morishita, R., Kaneda, Y., Kim, H. J., Kim, Y. D., Lee, H. J., Lee, K. U., Park, J. Y., Kim, Y. H., Park, K. K., et al. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302236 · Cited by 48
Ackermann, L. W., Wollenweber, L. A., & Denning, G. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5112 · Cited by 53
Superoxide Anions Are Involved in Doxorubicin‐Induced ERK Activation in Hepatocyte Cultures
Navarro, R., Busnadiego, I., Ruiz‐Larrea, M. B., & Ruiz-Sanz, J. I. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.045 · Cited by 47
CDK4/6 and MAPK—Crosstalk as Opportunity for Cancer Treatment
Scheiblecker, L., Kollmann, K., & Sexl, V. (2020) · Pharmaceuticals · doi:10.3390/ph13120418 · Cited by 55
“AP-1 member are also subject to ph sphorylati n by the MAPK pathway as has been sh wn for the -FOS protein [38].”
BackgroundSiddiq, A., Aminova, L. R., & Ratan, R. R. (2007) · Frontiers in bioscience · doi:10.2741/2892 · Cited by 49
Kitamura, S., Miyazaki, Y., Hiraoka, S., Nagasawa, Y., Toyota, M., Takakura, R., Kiyohara, T., Shinomura, Y., & Matsuzawa, Y. (2001) · International Journal of Cancer · doi:10.1002/ijc.1470 · Cited by 53
Schweppe, R. E., Cheung, T. H., & Ahn, N. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604208200 · Cited by 52
1α,25(OH)2-Vitamin D3 stimulates intestinal cell p38 MAPK activity and increases c-Fos expression
Pardo, V. G., Boland, R., & de Boland, A. R. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.12.018 · Cited by 50
Interleukin-1β Stimulation of c-Jun NH2-Terminal Kinase Activity in Insulin-Secreting Cells
Major, C. D., & Wolf, B. A. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2721 · Cited by 47
Lewthwaite, J. C., Bastow, E. R., Lamb, K. J., Blenis, J., Wheeler-Jones, C. P. D., & Pitsillides, A. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510680200 · Cited by 47
Dj, P., Pirttiniemi, P. M., Kantomaa, T., Agnantis, N. J., & Basdra, E. K. (2005) · European Journal of Orthodontics · doi:10.1093/ejo/cji101 · Cited by 46
“The AP-1 transcription factor is involved in cellular proliferation, transformation and apoptosis ( Whitmarsh and Davis, 1996 ; Wisdom et al. , 1999 ). Apoptosis, or programmed cell death, plays a key role in embryogenesis, immunological competence and tissue homeostasis for cell removal and can be distinguished bioch…”
BackgroundBhat, P. V., Pandareesh, M. D., Khanum, F., & Tamatam, A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01142 · Cited by 51
“JNK, also known as stress-activated protein kinases, represents a group of enzymes activated by exposure of cells to environmental stressors (Whitmarsh and Davis, 1996).”
BackgroundMAP kinase phosphatase-1, a gatekeeper of the acute innate immune response
Kirk, S. G., Samavati, L., & Liu, Y. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117157 · Cited by 50
Prabhakaran, K., Chapman, G. D., & Gunasekar, P. G. (2011) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2011.560210 · Cited by 48
C-Fos Regulation by the MAPK and PKC Pathways in Intervertebral Disc Cells
Yokoyama, K., Hiyama, A., Arai, F., Nukaga, T., Sakai, D., & Mochida, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073210 · Cited by 46
“Three major MAPKs, including extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 kinase, are regulated by distinct signal pathways that control many aspects of cellular physiology, including cell growth, differentiation, and apoptosis [5-7].”
BackgroundThe GluK4 kainate receptor subunit regulates memory, mood, and excitotoxic neurodegeneration
Lowry, E. R., Kruyer, A., Norris, E. H., Cederroth, C. R., & Strickland, S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.029 · Cited by 53
“Downstream of their activation, phosphorylated JNK isoforms regulate the activity of activator protein 1 (AP-1), a transcription factor that modulates various cellular processes including apoptosis (Whitmarsh and Davis, 1996).”
BackgroundFrequency and Distribution of AP-1 Sites in the Human Genome
Zhou, H. (2005) · DNA Research · doi:10.1093/dnares/12.2.139 · Cited by 46
Lan, C.-C. E., Wu, C., Huang, S., Kuo, H., Wu, I.-H., Wen, C.-H., Chai, C., Fang, A.-H., & Chen, G. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00091 · Cited by 53
Newer Immunosuppressive Drugs: Their Potential Role in Rheumatoid Arthritis Therapy
Drosos, A. A. (2002) · Drugs · doi:10.2165/00003495-200262060-00003 · Cited by 51
“Transcription factors are phosphorylated by specific proximal kinases and such phosphorylation can change the subcellular localisation of the transcription factor or its affinity for DNA, which in turn alters gene expression.[13,14] The activity of at least three transcription factors relevant to the inflammatory proc…”
BackgroundPapachristou, D. J., Papachristou, G. I., Papaefthimiou, O. A., Agnantis, N. J., Basdra, E. K., & Papavassiliou, A. G. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02266.x · Cited by 50
“crine, paracrine and hormonal stimuli that exert their effect via different receptor families, mainly receptor tyrosine kinases, cytokine receptors and G-proteincoupled receptors.(35,36) Activation of these transduction pathways is associated with tumorigenesis in several human tissues, including breast, lung, skin, p…”
BackgroundGhahremani, M. H., Keramaris, E., Shree, T., Xia, Z., Davis, R. J., Flavell, R. A., Slack, R. S., & Park, D. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204362200 · Cited by 50
Self-citationWilmer, W. A., & Cosio, F. G. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00888.x · Cited by 46
“protein kinase (MAPK), ERK [19, 20] can increase AP-1 binding”
BackgroundKim, C., Ryu, H.-C., & Kim, J.-H. (2010) · Experimental and Molecular Medicine · doi:10.3858/emm.2010.42.12.086 · Cited by 45
Galdiero, M., Vitiello, M., Sanzari, E., D’Isanto, M., Tortora, A., Longanella, A., & Galdiero, S. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.558-568.2002 · Cited by 45
“The AP-1 protein function is regulated primarily by phosphoregulation (55).”
BackgroundKim, H. W., Murakami, A., Abe, M., Ozawa, Y., Morimitsu, Y., Williams, M. V., & Ohigashi, H. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1621 · Cited by 54
Papachristou, D. J., Pirttiniemi, P. M., Kantomaa, T., Papavassiliou, A. G., & Basdra, E. K. (2005) · Histochemistry and Cell Biology · doi:10.1007/s00418-005-0026-8 · Cited by 50
“Specifically, phosphorylated JNK MAPKs trigger the transcription factor c-Jun by phosphorylating modulatory residues mapping within its N-terminal transactivation domain (Karin 1995; Whitmarsh and Davis 1996).”
BackgroundDai, X., Sayama, K., Tohyama, M., Shirakata, Y., Hanakawa, Y., Tokumaru, S., Yang, L., Hirakawa, S., & Hashimoto, K. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.09.008 · Cited by 45
Shibata, A., Nakagawa, K., Kawakami, Y., Tsuzuki, T., & Miyazawa, T. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf100691g · Cited by 46
Jung, M. K., Ha, S., Son, J.-A., Song, J. H., Houh, Y., Cho, E., Chun, J. H., Yoon, S. R., Yang, Y., Bang, S. I., et al. (2012) · Archives of Dermatological Research · doi:10.1007/s00403-012-1249-x · Cited by 48
“AP-1 is a transcription factor which is a heterodimeric protein composed of proteins belonging to the Fos and Jun family and its expression level is relatively constant [7, 44].”
BackgroundAllen, M. P., Xu, M., Linseman, D. A., Pawlowski, J. E., Bokoch, G. M., Heidenreich, K. A., & Wierman, M. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200826200 · Cited by 45
McMorran, B. J., Town, L., Costelloe, E. O., Palmer, J. S., Engel, J. N., Hume, D. A., & Wainwright, B. J. (2003) · Infection and Immunity · doi:10.1128/iai.71.10.6035-6044.2003 · Cited by 45
“The c-Fos protein forms heterodimeric complexes with members of Jun protein family called AP1, which functions as a transcriptional activator of genes involved in cell protection and survival ( 65 ).”
BackgroundSanz‐Moreno, V., Casar, B., & Crespo, P. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.9.3079-3090.2003 · Cited by 45
“By contrast, JNKs and p38 are preferentially induced by stressinducing agents and proinflammatory cytokines, although activation of various MAPK pathways by the same stimuli often occurs (32, 45).”
BackgroundThe Effects of Thiazolidinediones on Vascular Smooth Muscle Cell Activation by Angiotensin II
Hattori, Y., Akimoto, K., & Kasai, K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3084 · Cited by 45
IN VIVO AND IN VITRO CORRELATION OF PULMONARY MAP KINASE ACTIVATION FOLLOWING METALLIC EXPOSURE
Silbajoris, R. A. (2000) · Inhalation Toxicology · doi:10.1080/089583700402860 · Cited by 50
“Signaling through the MAPK pathways culminates in the phosphorylation-dependent activation of a variety of transcription factors that modulate cytokine gene expression (Su & Karin, 1996; Treisman, 1996; Whitmarsh & Davis, 1996).”
BackgroundWang, C., Ren, Q., Chen, X., Song, Z., Ning, Z., Gan, J.-H., Ma, X., Liang, D., Guan, D.-G., Liu, Z., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00841 · Cited by 49
“, 2014); MAPK8 was mediators of signal transduction from the cell surface to the nucleus, and can regulate AP-1 transcriptional activity by multiple mechanisms (Whitmarsh and Davis, 1996); JUN were phosphorylated through homeodomaininteracting protein kinase 3 after cAMP stimulation (Lan et al.”
BackgroundLee, J., Park, H., Oh, Y., Kim, Y.-J., Youn, J., Han, J., & Kim, J. M. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0237-7 · Cited by 45
“All of these signaling cascades have been shown to regulate AP-1 activity and are implicated in the control of IL-8 transcription [15].”
BackgroundEvans, M. C., Lord, R. A., & Anderson, G. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179210 · Cited by 55
“One important nuclear target of ERK1/2 signalling is AP-1; a transcription factor complex composed of Jun and Fos family members that binds to specific control elements in numerous genes that regulate cell differentiation and proliferation [73].”
BackgroundNeurofilaments in diabetic neuropathy
Fernyhough, P., & Schmidt, R. E. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)50075-1 · Cited by 47
Haase, R., Richter, K., Pfaffinger, G., Courtois, G., & Ruckdeschel, K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8209 · Cited by 51
“The AP-1-dependent reporter gene can respond to induction of the JNK, ERK1/2, or p38 MAPK pathways in dependence on the composition of the AP-1 dimer (37, 38).”
BackgroundBoss, V., Roback, J. D., Young, A. N., Roback, L., Weisenhorn, D. M. V., Medina‐Flores, R., & Wainer, B. H. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00018.2001 · Cited by 44
“…Grb2, which trigger the well known Ras/Raf/MAP kinase pathway, as well as phosphoinositide-3 kinase (PI-3 kinase) and phospholipase C3g (PLCg), which activate additional signaling cascades (for review, see Chao, 1992; Greene and Kaplan, 1995; Marshall, 1995; Whitmarsh and Davis, 1996; Wells, 1999).”
BackgroundJeon, Y., Kook, S., Son, Y., Kim, E. M., Park, S., Kim, J., & Lee, J. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9897-z · Cited by 46
“AP-1 synthesis and activation is mediated by various bone-active signals, where members of the MAPK family play important roles [13, 22].”
Metadata
- Authors
- Whitmarsh, A. J., & Davis, R. J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Journal of Molecular Medicine
- Published
- 1996-10
- Volume
- 74
- Issue
- 10
- Pages
- 589-607
- ISSN
- 0946-2716 (ISSN-L)
- OpenAlex
- W2031272027
- Cited by
- 1,543
- References
- 207
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 22 · 2023: 25 · 2022: 22 · 2021: 19 · 2020: 27 · 2019: 20 · 2018: 28 · 2017: 29 · 2016: 29 · 2015: 39 · 2014: 34 · 2013: 40 · 2012: 37
- FWCI
- 24.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- AP-1 transcription factor, mitogen-activated protein kinase, ERK, c-Jun N-terminal kinase, p38 MAPK, MAPK signaling, transcriptional regulation, dual phosphorylation, signal transduction
- MeSH terms
- Animals, Humans, Mammals, Signal Transduction, Calcium-Calmodulin-Dependent Protein Kinases, Transcription Factor AP-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.